PCI Biotech Holding ASA (OSL:PCIB)
0.2810
-0.0220 (-7.26%)
Oct 3, 2025, 4:17 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 10.49 million as of October 3, 2025. Its market cap has decreased by -84.12% in one year.
Market Cap
10.49M
Enterprise Value
-2.85M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 10.49M, a decrease of -89.24%. That is a compound annual growth rate of -12.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 11.31M | -74.49% |
Dec 30, 2024 | 44.34M | -43.29% |
Dec 29, 2023 | 78.20M | 2.20% |
Dec 30, 2022 | 76.52M | -85.26% |
Dec 30, 2021 | 519.21M | -50.14% |
Dec 30, 2020 | 1.04B | -63.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Medistim ASA | 4.28B |
Nordhealth AS | 2.85B |
Photocure ASA | 1.56B |
ArcticZymes Technologies ASA | 1.36B |
Thor Medical ASA | 1.25B |
Omda AS | 1.04B |
Vistin Pharma ASA | 1.02B |
Gentian Diagnostics ASA | 848.23M |